Curaleaf Holdings (CURLF) Accumulated Expenses (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Accumulated Expenses of $110.5 million in Q4 2025, up 8.13% quarter-over-quarter from $102.2 million in Q4 2024, and up 8.13% on a YoY basis from $102.2 million in Q4 2024.
Curaleaf Holdings (CURLF) Accumulated Expenses (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $110.5 million for Q4 2025.
- In Q4 2025, Accumulated Expenses rose 8.13% year-over-year to $110.5 million; the TTM figure through Dec 2025 stood at $110.5 million (up 8.13% YoY), while the FY2025 annual figure was $110.5 million, up 8.13% from the prior year.
- Accumulated Expenses was $110.5 million for Q4 2025 at Curaleaf Holdings, up from $102.2 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $296.5 million in Q3 2024 to a low of -$8.1 million in Q1 2021.
- Historically, Accumulated Expenses has averaged $95.0 million across 5 years, with a median of $89.5 million in 2022.
- Biggest YoY gain for Accumulated Expenses was 3166.12% in 2021; the steepest drop was 336.44% in 2021.
- A 5-year view of Accumulated Expenses shows it stood at $87.0 million in 2021, then tumbled by 41.4% to $51.0 million in 2022, then surged by 98.8% to $101.3 million in 2023, then rose by 0.87% to $102.2 million in 2024, then gained by 8.13% to $110.5 million in 2025.
- The last three Accumulated Expenses figures came in at $110.5 million (Q4 2025), $102.2 million (Q4 2024), and $296.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 110.49 Mn |
| Dec 31, 2024 | 102.19 Mn |
| Sep 30, 2024 | 296.53 Mn |
| Jun 30, 2024 | 253.59 Mn |
| Dec 31, 2023 | 101.31 Mn |
| Sep 30, 2023 | 100.97 Mn |
| Jun 30, 2023 | 105.46 Mn |
| Dec 31, 2022 | 50.96 Mn |
| Sep 30, 2022 | -3.99 Mn |
| Jun 30, 2022 | 89.46 Mn |
| Mar 31, 2022 | -430,000.00 |
| Dec 31, 2021 | 86.97 Mn |
| Sep 30, 2021 | 80.65 Mn |
| Jun 30, 2021 | 59.67 Mn |
| Mar 31, 2021 | -8.09 Mn |
| Dec 31, 2020 | 57.48 Mn |
| Sep 30, 2020 | 44.81 Mn |
| Jun 30, 2020 | 1.83 Mn |
| Mar 31, 2020 | 3.42 Mn |
| Dec 31, 2019 | 18.02 Mn |